Cargando…

New adaptive lasso approaches for variable selection in automated pharmacovigilance signal detection

BACKGROUND: Adverse effects of drugs are often identified after market introduction. Post-marketing pharmacovigilance aims to detect them as early as possible and relies on spontaneous reporting systems collecting suspicious cases. Signal detection tools have been developed to mine these large datab...

Descripción completa

Detalles Bibliográficos
Autores principales: Courtois, Émeline, Tubert-Bitter, Pascale, Ahmed, Ismaïl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8638444/
https://www.ncbi.nlm.nih.gov/pubmed/34852782
http://dx.doi.org/10.1186/s12874-021-01450-3
_version_ 1784608946416254976
author Courtois, Émeline
Tubert-Bitter, Pascale
Ahmed, Ismaïl
author_facet Courtois, Émeline
Tubert-Bitter, Pascale
Ahmed, Ismaïl
author_sort Courtois, Émeline
collection PubMed
description BACKGROUND: Adverse effects of drugs are often identified after market introduction. Post-marketing pharmacovigilance aims to detect them as early as possible and relies on spontaneous reporting systems collecting suspicious cases. Signal detection tools have been developed to mine these large databases and counts of reports are analysed with disproportionality methods. To address disproportionality method biases, recent methods apply to individual observations taking into account all exposures for the same patient. In particular, the logistic lasso provides an efficient variable selection framework, yet the choice of the regularization parameter is a challenging issue and the lasso variable selection may give inconsistent results. METHODS: We propose a new signal detection methodology based on the adaptive lasso. We derived two new adaptive weights from (i) a lasso regression using the Bayesian Information Criterion (BIC), and (ii) the class-imbalanced subsampling lasso (CISL), an extension of stability selection. The BIC is used in the adaptive lasso stage for variable selection. We performed an extensive simulation study and an application to real data, where we compared our methods to the existing adaptive lasso, and recent detection approaches based on lasso regression or propensity scores in high dimension. For both studies, we evaluate the methods in terms of false discoveries and sensitivity. RESULTS: In the simulations and the application, both proposed adaptive weights show equivalent or better performances than the other competitors, with an advantage for the CISL-based adaptive weights. CISL and lasso regression using BIC are solid alternatives. CONCLUSION: Our proposed adaptive lasso is an appealing methodology for signal detection in pharmacovigilance. Although we cannot rely on test theory, our approaches show a low and stable False Discovery Rate in all simulation settings. All methods evaluated in this work are implemented in the adapt4pv R package. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at (10.1186/s12874-021-01450-3).
format Online
Article
Text
id pubmed-8638444
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-86384442021-12-03 New adaptive lasso approaches for variable selection in automated pharmacovigilance signal detection Courtois, Émeline Tubert-Bitter, Pascale Ahmed, Ismaïl BMC Med Res Methodol Research BACKGROUND: Adverse effects of drugs are often identified after market introduction. Post-marketing pharmacovigilance aims to detect them as early as possible and relies on spontaneous reporting systems collecting suspicious cases. Signal detection tools have been developed to mine these large databases and counts of reports are analysed with disproportionality methods. To address disproportionality method biases, recent methods apply to individual observations taking into account all exposures for the same patient. In particular, the logistic lasso provides an efficient variable selection framework, yet the choice of the regularization parameter is a challenging issue and the lasso variable selection may give inconsistent results. METHODS: We propose a new signal detection methodology based on the adaptive lasso. We derived two new adaptive weights from (i) a lasso regression using the Bayesian Information Criterion (BIC), and (ii) the class-imbalanced subsampling lasso (CISL), an extension of stability selection. The BIC is used in the adaptive lasso stage for variable selection. We performed an extensive simulation study and an application to real data, where we compared our methods to the existing adaptive lasso, and recent detection approaches based on lasso regression or propensity scores in high dimension. For both studies, we evaluate the methods in terms of false discoveries and sensitivity. RESULTS: In the simulations and the application, both proposed adaptive weights show equivalent or better performances than the other competitors, with an advantage for the CISL-based adaptive weights. CISL and lasso regression using BIC are solid alternatives. CONCLUSION: Our proposed adaptive lasso is an appealing methodology for signal detection in pharmacovigilance. Although we cannot rely on test theory, our approaches show a low and stable False Discovery Rate in all simulation settings. All methods evaluated in this work are implemented in the adapt4pv R package. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at (10.1186/s12874-021-01450-3). BioMed Central 2021-12-01 /pmc/articles/PMC8638444/ /pubmed/34852782 http://dx.doi.org/10.1186/s12874-021-01450-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Courtois, Émeline
Tubert-Bitter, Pascale
Ahmed, Ismaïl
New adaptive lasso approaches for variable selection in automated pharmacovigilance signal detection
title New adaptive lasso approaches for variable selection in automated pharmacovigilance signal detection
title_full New adaptive lasso approaches for variable selection in automated pharmacovigilance signal detection
title_fullStr New adaptive lasso approaches for variable selection in automated pharmacovigilance signal detection
title_full_unstemmed New adaptive lasso approaches for variable selection in automated pharmacovigilance signal detection
title_short New adaptive lasso approaches for variable selection in automated pharmacovigilance signal detection
title_sort new adaptive lasso approaches for variable selection in automated pharmacovigilance signal detection
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8638444/
https://www.ncbi.nlm.nih.gov/pubmed/34852782
http://dx.doi.org/10.1186/s12874-021-01450-3
work_keys_str_mv AT courtoisemeline newadaptivelassoapproachesforvariableselectioninautomatedpharmacovigilancesignaldetection
AT tubertbitterpascale newadaptivelassoapproachesforvariableselectioninautomatedpharmacovigilancesignaldetection
AT ahmedismail newadaptivelassoapproachesforvariableselectioninautomatedpharmacovigilancesignaldetection